Edition:
United States

Vita 34 AG (V3VGn.DE)

V3VGn.DE on Xetra

15.20EUR
6:56am EST
Change (% chg)

€0.40 (+2.70%)
Prev Close
€14.80
Open
€15.10
Day's High
€15.20
Day's Low
€15.10
Volume
1,826
Avg. Vol
20,879
52-wk High
€17.00
52-wk Low
€5.40

Chart for

About

Vita 34 AG, is a Germany-based company that operates as an umbilical cord blood bank. It operates through the Stem Cell Storage and the Biotechnology segment. The Stem Cell Storage segment collects, processes, and stores stem cells from umbilical cord blood and umbilical cord tissue, as well as develops cell therapy procedures.... (more)

Overall

Beta: 0.35
Market Cap(Mil.): €61.36
Shares Outstanding(Mil.): 4.15
Dividend: 0.16
Yield (%): 1.05

Financials

  Industry Sector
P/E (TTM): -- 30.50 17.27
EPS (TTM): -- -- --
ROI: -- 6.26 35.43
ROE: -- 9.84 17.10

BRIEF-Vita 34 Q3 EBITDA up 50.1 pct at EUR 1.1 mln​

* ‍REVENUES IN Q3 INCREASED BY 39.5 PERCENT AS COMPARED WITH PRIOR YEAR TO EUR 5.6 MILLION (Q3 2016: EUR 4.0 MILLION)​

Nov 23 2017

BRIEF-Vita 34 and Berlin Charité start joint research project

* VITA 34 AND BERLIN CHARITÉ START JOINT RESEARCH PROJECT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 25 2017

BRIEF-Vita 34 H1 net result swings to loss of EUR 1.0 mln

* H1 REVENUE INCREASED BY 2.5 PERCENT AND GROSS PROFIT BY 14 PERCENT AS COMPARED WITH H1 2016

Aug 30 2017

Earnings vs. Estimates